Proteomic Screen Reveals Fbw7 As a Modulator of the NF-κB Pathway

Overview

Journal Nat Commun

Specialty Biology

Date 2012 Aug 7

PMID 22864569

Citations 53

Authors

Azadeh Arabi

Karim Ullah

Rui M M Branca

Johan Johansson

Daniel Bandarra

Moritz Haneklaus

Jing Fu

Ingrid Aries

Peter Nilsson

Monique L den Boer

Katja Pokrovskaja

Dan Grander

Gutian Xiao

Sonia Rocha

Janne Lehtio

Olle Sangfelt

Affiliations

Soon will be listed here.

Abstract

Fbw7 is a ubiquitin-ligase that targets several oncoproteins for proteolysis, but the full range of Fbw7 substrates is not known. Here we show that by performing quantitative proteomics combined with degron motif searches, we effectively screened for a more complete set of Fbw7 targets. We identify 89 putative Fbw7 substrates, including several disease-associated proteins. The transcription factor NF-κB2 (p100/p52) is one of the candidate Fbw7 substrates. We show that Fbw7 interacts with p100 via a conserved degron and that it promotes degradation of p100 in a GSK3β phosphorylation-dependent manner. Fbw7 inactivation increases p100 levels, which in the presence of NF-κB pathway stimuli, leads to increased p52 levels and activity. Accordingly, the apoptotic threshold can be increased by loss of Fbw7 in a p100-dependent manner. In conclusion, Fbw7-mediated destruction of p100 is a regulatory component restricting the response to NF-κB2 pathway stimulation.

Citing Articles

Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7.

Boretto M, Geurts M, Gandhi S, Ma Z, Staliarova N, Celotti M Proc Natl Acad Sci U S A. 2024; 121(12):e2309902121.

PMID: 38483988 PMC: 10962967. DOI: 10.1073/pnas.2309902121.

Biallelic FBXW7 knockout induces AKAP8-mediated DNA damage in neighbouring wildtype cells.

Chan D, Mandal A, Hester S, Yu Z, Higgins G, Kessler B Cell Death Discov. 2023; 9(1):200.

PMID: 37386001 PMC: 10310709. DOI: 10.1038/s41420-023-01494-y.

Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases.

Zhang X, Liu Y, Zhang T, Tan Y, Dai X, Yang Y Front Immunol. 2023; 14:1125224.

PMID: 37006236 PMC: 10064048. DOI: 10.3389/fimmu.2023.1125224.

FBXW7β isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells.

Yang S, Hayer K, Fazelinia H, Spruce L, Asnani M, Black K Blood Adv. 2022; 7(7):1077-1091.

PMID: 36322817 PMC: 10111352. DOI: 10.1182/bloodadvances.2022007910.

NF-κB and its crosstalk with endoplasmic reticulum stress in atherosclerosis.

Li W, Jin K, Luo J, Xu W, Wu Y, Zhou J Front Cardiovasc Med. 2022; 9:988266.

PMID: 36204587 PMC: 9530249. DOI: 10.3389/fcvm.2022.988266.

References

Keats J, Fonseca R, Chesi M, Schop R, Baker A, Chng W . Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell. 2007; 12(2):131-44. PMC: 2083698. DOI: 10.1016/j.ccr.2007.07.003. View

den Boer M, van Slegtenhorst M, de Menezes R, Cheok M, Buijs-Gladdines J, Peters S . A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2):125-34. PMC: 2707020. DOI: 10.1016/S1470-2045(08)70339-5. View

Nash P, Tang X, Orlicky S, Chen Q, Gertler F, Mendenhall M . Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature. 2001; 414(6863):514-21. DOI: 10.1038/35107009. View

Xiao G, Harhaj E, Sun S . NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell. 2001; 7(2):401-9. DOI: 10.1016/s1097-2765(01)00187-3. View

Orlicky S, Tang X, Willems A, Tyers M, Sicheri F . Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell. 2003; 112(2):243-56. DOI: 10.1016/s0092-8674(03)00034-5. View

Hao B, Oehlmann S, Sowa M, Harper J, Pavletich N . Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell. 2007; 26(1):131-43. DOI: 10.1016/j.molcel.2007.02.022. View

Derudder E, Dejardin E, Pritchard L, Green D, Korner M, Baud V . RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. J Biol Chem. 2003; 278(26):23278-84. DOI: 10.1074/jbc.M300106200. View

Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U . The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem. 2001; 276(38):35847-53. DOI: 10.1074/jbc.M103992200. View

van Drogen F, Sangfelt O, Malyukova A, Matskova L, Yeh E, Means A . Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol Cell. 2006; 23(1):37-48. DOI: 10.1016/j.molcel.2006.05.020. View

10.

Tan Y, Sangfelt O, Spruck C . The Fbxw7/hCdc4 tumor suppressor in human cancer. Cancer Lett. 2008; 271(1):1-12. DOI: 10.1016/j.canlet.2008.04.036. View

11.

Tetzlaff M, Yu W, Li M, Zhang P, Finegold M, Mahon K . Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci U S A. 2004; 101(10):3338-45. PMC: 373463. DOI: 10.1073/pnas.0307875101. View

12.

Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng H, Akbari Moqadam F . MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle. 2011; 10(13):2172-83. DOI: 10.4161/cc.10.13.16248. View

13.

Eriksson H, Lengqvist J, Hedlund J, Uhlen K, Orre L, Bjellqvist B . Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms. Proteomics. 2008; 8(15):3008-18. DOI: 10.1002/pmic.200800174. View

14.

Strohmaier H, Spruck C, Kaiser P, Won K, Sangfelt O, Reed S . Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature. 2001; 413(6853):316-22. DOI: 10.1038/35095076. View

15.

Welcker M, Orian A, Jin J, Grim J, Grim J, Harper J . The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A. 2004; 101(24):9085-90. PMC: 428477. DOI: 10.1073/pnas.0402770101. View

16.

Welcker M, Clurman B . Fbw7/hCDC4 dimerization regulates its substrate interactions. Cell Div. 2007; 2:7. PMC: 1802738. DOI: 10.1186/1747-1028-2-7. View

17.

Blom N, Sicheritz-Ponten T, Gupta R, Gammeltoft S, Brunak S . Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics. 2004; 4(6):1633-49. DOI: 10.1002/pmic.200300771. View

18.

Perkins N . The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer. 2012; 12(2):121-32. DOI: 10.1038/nrc3204. View

19.

Xiao G, Fu J . NF-κB and cancer: a paradigm of Yin-Yang. Am J Cancer Res. 2011; 1(2):192-221. PMC: 3180046. View

20.

Sun S . Non-canonical NF-κB signaling pathway. Cell Res. 2010; 21(1):71-85. PMC: 3193406. DOI: 10.1038/cr.2010.177. View